NBIX director exercises 3,318 RSUs into shares
NEUROCRINE BIOSCIENCES INC director George J. Morrow exercised restricted stock units into common shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
NEUROCRINE BIOSCIENCES INC director George J. Morrow exercised restricted stock units into common shares. He converted 3,318 RSUs into 3,318 shares of common stock, increasing his direct common stock holdings to 10,386 shares. The RSU award, granted on May 21, 2025, was fully vested and each unit represented one share of common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 3,318 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,318 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.
- F2. This RSU award was granted to the Reporting Person on May 21, 2025 and is fully vested.
Key Figures
Key Terms
Restricted Stock Unit financial
RSU financial
derivative security financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did NBIX director George J. Morrow report?
What were the terms of the NBIX restricted stock units exercised by Morrow?
Does George J. Morrow still hold any NBIX restricted stock units after this transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.